PLUS THERAPEUTICS, INC. — Director's Dealing 2010

Feb 9, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-02-05

Reporting Person: HEDRICK MARC H (Director, President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-05	Employee Stock Option (Right to Buy)	$6.71	A	110000	Acquired	2020-02-05	Common Stock (110000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	448238	Direct
Common Stock	4000	Indirect
Common Stock	7800	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$2.62	2014-05-12	Common Stock (35000)	35000	Direct

Footnotes

F1: The Employee Stock Options vest 1/48th each month from date of grant.